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There are challenges in viridans group streptococci (VGS) identification especially for
the mitis group. Few studies have investigated the performance of MALDI-TOF MS
system in VGS identification. Using 16S rRNA gene and gyrB gene sequencing as a
gold standard, the performance of two MALDI-TOF MS instruments in the identification
of 181 VGS clinical isolates was studied. The Bruker Biotyper and Vitek MS IVD
systems correctly identified 88.4% and 98.9% of the 181 isolates, respectively. The
Vitek MS RUO system was the least reliable, only correctly identifying 38.7% of the
isolates to species level with several misidentifications and invalid results. The Bruker
Biotyper system was very unreliable in the identification of species within the mitis
group. Among 22 non-pneumococci isolates (S. mitis/S. oralis/S. pseudopneumoniae),
Biotyper misidentified 21 of them as S. pneumoniae leading to a low sensitivity and low
positive predictive value in these species. In contrast, the Vitek MS IVD demonstrated
a better resolution for pneumococci and non-pneumococci despite the inability to
distinguish between S. mitis/S. oralis. For more accurate species-level identification,
further improvements in the VGS spectra databases are needed. Based on MALDI-TOF
analysis and selected 16S rRNA gene plus gyrB genes sequencing, we designed a
practical VGS identification algorithm.
Keywords: Streptococcus, viridans group streptococci (VGS), matrix-assisted laser desorption ionization-time of
flight (MALDI-TOF), 16S rRNA gene, gyrB gene
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INTRODUCTION
The viridans group streptococci (VGS) are a heterogeneous
group of gram positive cocci, which form part of the normal
human flora of the oral cavity, respiratory, urogenital, and
gastrointestinal tracts (Spellberg and Brandt, 2011). Currently,
VGS is subdivided into six major groups: S. anginosus, S. bovis,
S. mitis, S. mutans, S. salivarius, and S. sanguinis (Facklam,
2002; Doern and Burnham, 2010). Accurate identification of
species within the VGS group is important for assessing the
clinical significance of the organism and to facilitate appropriate
antimicrobial therapy (Sinner and Tunkel, 2009; Doern and
Burnham, 2010). However, due to constant taxonomic changes
in the VGS group, identification of species is challenging. No
phenotypic identification method can be used as a gold standard
for VGS as most methods, including API Strep, and Vitek 2, have
only 30–80% identification accuracy, depending on the species
(Ikryannikova et al., 2011; Teles et al., 2011).
Sequence analysis targeting different single genes such as 16S
rRNA gene, rpoA, rpoB, rnpB, rodA, soda, and gdh, have been
used in the identification of VGS species with various degrees
of success (Poyart et al., 1998; Ip et al., 2006; Westling et al.,
2008; Konishi et al., 2009; Nielsen et al., 2009; Park et al.,
2010). Currently, only multilocus sequence analysis (MLSA) can
accurately and reliably identify species within the VGS group.
But MLSA is too expensive and laborious for routine laboratory
diagnostic use (Bishop et al., 2009). Recently, Galloway-Peña
et al. reported that the gyrB amino acid sequencemay offer amore
practical and accurate method for speciating invasive VGS strains
than MLSA (Galloway-Pena et al., 2014).
In recent years, matrix-assisted laser desorption ionization-
time of flight (MALDI-TOF) has emerged as a rapid and cost-
effective alternative assay for bacterial identification (Seng et al.,
2009; Bizzini et al., 2010; Neville et al., 2011). Nevertheless, some
studies indicate that this assay has problems in distinguishing
species within the S. mitis group (Ikryannikova et al., 2011; Davies
et al., 2012; Wessels et al., 2012).
We investigated the performance of two MALDI-TOF MS
systems, namely Bruker Biotyper (Daltonics, German) and Vitek
MS (bioMérieux, France) in the identification of species within
the VGS group, using sequencing of the 16S rRNA, and gyrB
genes as a gold standard.
MATERIALS AND METHODS
Bacterial Strains and Cultures
Clinically significant VGS isolates (n = 181) from sputum
(n = 81), blood cultures (n = 29), tracheal aspirates (n = 11),
midstream urine (n = 9), and other various sterile and non-
sterile sites (n = 51) from Peking Union Medical College
Hospital (PUMCH; 2013–2014), were studied (Supplementary
Table S1). Initial identification of these isolates was done by
Abbreviations: MALDI-TOF, matrix-assisted laser desorption ionization-time of
flight; VGS, viridans group streptococci; MLSA: multilocus sequence analysis;
PUMCH, Peking Union Medical College Hospital; IVD, In Vitro Diagnosis; RUO,
Research Use Only; CI, confidence interval; PPV, positive predictive value; NPV,
negative predictive value
conventional methods (positive Gram stain, coccus morphology
in chains, alpha-hemolysis, and a negative catalase test) and
Vitek 2 compact system. Optochin and bile solubility tests were
performed to differentiate pneumococci from non-pneumococci.
The isolates were stored at −70◦C in skim milk until further
testing.
Gene Sequencing-Based Identification
Template DNA was prepared as described by. Dubois et al.
(2013). The16S rRNA gene was amplified for all the isolates using
the universal primers 27F 5′-AGAGTTTGATCMTGGCTCAG-
3′ and 1492R 5′-TACGGYTACCTTGTT ACGACTT-3′
(Seng et al., 2009). Purified PCR products and sequencing
primers (the same as for amplification) were mixed and
sent to Ruibiotech (Beijing, China) for sequencing. Species
identification was performed by comparing the obtained
sequences against those in the GenBank database using
BLASTn (www.ncbi.nlm.nih.gov/blast). A sequence similarity
of 99% was applied as species identification “cut-off” value
for the 16S rRNA gene region. Amplification and sequencing
of the gyrB gene encoding DNA Gyrase subunit B was
performed for all the non-pneumococci using primers gyrB7F
5′-GAAGTDGTIAARATYACBAAY CG-3′ and gyrB5R 5′-
ACATCDGCATCRGTCAT-3′ (Maeda et al., 2011). Both the
gyrB nucleotide and amino acid sequences were analyzed
through BLASTn and BLASTp and a nucleotide sequence
similarity of 96% or a signature amino acid at a certain position
was applied as species identification standard according to
Galloway-Pena et al. (2014). Besides, the phylogenetic trees
were generated based on 16S rRNA gene and gyrB gene. The
region used for phylogenetic analyses and species identification
was nucleotides 86–1336 for 16S rRNA gene and nucleotides
1113–1512, corresponding to amino acids 371–503 for gyrB gene
respectively. Following alignment with Clustal W, the sequences
were analyzed in MEGA version 5.2 to create radial trees using
the neighbor-joining statistical method and the maximum
likelihood composite model.
MALDI-TOF Analysis
Two MALDI-TOF MS systems, Bruker Biotyper and Vitek MS,
including both the In Vitro Diagnosis (IVD) and Research
Use Only (RUO) modes were used to identify the 181 VGS
isolates, according to the manufacturer’s instructions. For
both MALDI-TOF MS systems, direct transfer method were
used for sample preparation. A small portion of a single
colony after 24 or 48 h of incubation was smeared onto
a target plate using a wooden cocktail stick, and covered
with 1 µl matrix solution (α- cyano-4-hydroxycinnamic acid
in 50 acetonitrile/2.5% trifluoroacetic acid, Bruker Daltonics,
Bremen, Germany; α-cyano-4-hydroxycinnamic acid, VITEK R©
MS CHCA) immediately. For Bruker Biotyper, measurements
were performed with the Bruker Biotyper MALDI-TOF MS
system using FlexControl software with Compass Flex Series
version 1.3 software and a 60-Hz nitrogen laser (337 nm
wavelength). Spectra ranging from 2000 to 20,000 m/z were
analyzed using the MALDI Biotyper system’s automation
control and the current Bruker Biotyper V.3.3.1.2 software and
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library [database (DB) 5989 with 5989 entries]. For Vitek MS,
measurement was performed using the manufacturer’s suggested
settings using automated collecting spectra. Captured spectra
(mass range of 2–20 kDa in the linear mode) were analyzed
using the MALDI-TOF MS IVD MYLA database v2.0 and also
theMALDI-TOFMSRUOsystemwith the SARAMIS
TM
database
v4.10 of bioMérieux. All identifications displaying a single result
with a confidence score ≥1.7 or a confidence value of 99.9%
were considered acceptable for Bruker Biotyper MS and Vitek
MS, respectively (Karpanoja et al., 2014). For both MS systems,
all isolates yielding a single result without acceptable confidence
level or multiple results or “no identification” results were re-
tested. If a single, species-level identification was obtained upon
repeat analysis, this identification was considered to be the final
MS result; otherwise no further analysis was performed.
Statistical Analysis
Agreement and validity values were calculated with a 95%
confidence interval (CI) based on an exact binomial distribution.
Data were analyzed using SPSS, version 15.0 (SPSS Inc, Chicago,
IL, USA).
RESULTS
The 16S rRNA Gene and GyrB Gene
Sequencing-Based Identification
Using a combination of 16S rRNA gene and gyrB gene
sequencing, all the 181 VGS isolates were assigned to species
level on the basis of a ≥99 and ≥96% gene sequence similarity
with published sequences in theGenBank. TheDNA sequences of
the16S rRNA gene and gyrB gene of the 181 VGS isolates studied
have been submitted to GenBank database (accession numbers
of KX661043–KX661223 for 16S rRNA gene and KX661224–
KX661319 for gyrB gene respectively (Supplementary Table S2).
Figure 1 shows the phylogenetic trees generated by gyrB gene
and 16S rRNA gene. As is shown in Figure 1A, gyrB nucleotide
sequence successfully delineated all of the 96 non-pneumococci
strains into individual species branches while in Figure 1B, all of
the S. oralis isolates were branched with S. mitis isolates by 16S
rRNA sequences. Besides, the bootstrap values between the mitis
group were rather low compared to gyrB gene, which emphasizs
the difficulties of using 16S gene sequences to correctly assign
VGS strains to particular species. The identification results of the
181 VGS isolates are summarized in Supplementary Tables S3, S4,
and S5, using gene sequencing as the gold standard.
A high level of similarity in the 16S rRNA gene sequences of S.
pneumoniae, S. pseudopneumoniae, S. mitis, and S. oralis, which
could make it difficult in distinguishing these species, has been
reported (Kawamura et al., 1995; Arbique et al., 2004; Suzuki
et al., 2005; Haanpera et al., 2007). Nevertheless, a recent study
by Scholz et al. demonstrated that S. pneumoniae has a cytosine
at position 203 of the 16S rRNA gene, while all other mitis group
streptococci have adenine in that position (Scholz et al., 2012). In
this study, we also checked position 203 of the 16S rRNA gene
sequences, and confirmed that 85 isolates were pneumococci and
the other 96 isolates non-pneumococci.
MALDI-TOF Analysis
Compared to the gold standard, the Bruker Biotyper system
correctly identified 88.4% (160/181) of the isolates to species
level and misidentified 11.6% (21/181) of the isolates. This
system performed poorly in the identification of species in
FIGURE 1 | Phylogenetic analyses using 16S rRNA and gyrB fragment sequences. (A) Phylogenetic analysis using the gyrB sequence from nucleotides
1113–1512. (B) Phylogenetic analysis using the 16S rRNA sequence from nucleotides 86 to 1336.
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the mitis group, correctly identifying 80.4% (86/107) of the
isolates to species level and misidentifying 19.6% (21/107) of
the isolates. Optochin tests were performed on all isolates with
an identification result of S. pneumoniae in an atmosphere
of 5% CO2, among which 85 isolates were sensitive and the
other 21 were resistant. Specifically, 100 (11/11), 100 (2/2),
and 88.9% (8/9) of S. mitis, S. oralis, and S. pseudopneumoniae
isolates were misidentified as S. pneumoniae, respectively. For all
other groups, the Bruker Biotyper system performed excellently,
accurately identifying all the species within each of the respective
groups. Furthermore, the system did not yield an invalid or “no
identification result” on any isolates (Supplementary Table S3).
Vitek MS IVD correctly identified 98.9 (179/181) of the
VGS isolates to species level, 0.55 (1/181) to group level, and
0.55% (1/181) with no identification. In contrast to the Bruker
MS system which performed dismally in the identification
of S. pseudopneumoniae isolates, the Vitek MS IVD correctly
identified the majority (8 of 9, 88.9%) of these isolates to
species level and the remaining one isolate to group level
(Supplementary Table S4). Furthermore, the Vitek MS IVD gave
a “no identification” result on one isolate within the bovis group
(S. gallolyticus).
In comparison to Bruker Biotyper and Vitek MS IVD,
the Vitek MS RUO system performed very poorly in VGS
identification, with an overall correct species level, group level,
and genus level identification rate of 38.7 (70/181), 42.0 (76/181),
and 7.2% (13/181) respectively (Supplementary Table S5). The
system especially performed poorly in identifying species within
the mitis and bovis groups, with only 15.9 (17/107) and 25%
(2/8) of the isolates correctly identified, albeit low number of
isolates. In addition, 8.8 (16/181) and 3.3% (6/181) of the isolates
studied were misidentified and yielded a “no identification”
result, respectively.
Three MALDI-TOF Systems Comparisons
Sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) of the three databases are shown
in Table 1. Overall, Bruker Biotyper gave a 100% sensitivity
for the majority of the species identified, except for the mitis
group species, namely S. mitis (0%), S. oralis (0%), and S.
pseudopneumoniae (11.1%), most of which were misidentified
as S. pneumoniae (21 of 22, 95.6%). Furthermore, PPV was
incalculable for S. mitis and S. oralis as none of these isolates
were correctly identified by the Bruker Biotyper. In contrast to
other species in the mitis group, S. pneumoniae, had a 100%
(95 CI: 95.8–100.0%) sensitivity and a 100% (95 CI: 95.5–
100.0%) NPV, while the specificity and PPV were relatively low,
at 78.1% (95 CI:68.5–85.9%) and 80.2% (95 CI:71.3%–87.3%),
respectively.
Compared with Bruker Biotyper, Vitek MS IVD gave a better
resolution for S. mitis/S. oralis identification with a sensitivity
of 100% (95 CI: 75.3–100%) though the two species couldn’t
be distinguished from each other due to database limitation.
Similarly, the overall sensitivity for S. pseudopneumoniae
identification [77.8% (95 CI: 40.0–97.2%)] was higher than that
of Bruker Biotyper [11.1% (95 CI: 0.3–48.3%)].
Expectedly, Vitek MS RUO showed low sensitivity for the
identification of most species, except for S. anginosus, S.
intermedius, S. sanguinis, S. gordonii, and S. salivarius.
DISCUSSION
Currently, only three studies have compared the performance
of Bruker Biotyper vs. Vitek MS for VGS identification, with
two of the studies analyzing a limited number of blood culture
isolates (Karpanoja et al., 2014; Angeletti et al., 2015; Isaksson
et al., 2015). In two of the studies, 16S rRNA gene and rpoB
gene sequencing were used as a gold standard, while the third
study didn’t have a gold standard. Although the species/group
distributions were different in each of these three studies, they
all concluded that apart from the misidentification of other
species as S. pneumoniae by Bruker Biotyper, the MALDI-TOF
technique offers a reliable, rapid and cost saving method for VGS
identification.
We evaluated the performance of two MALDI-TOF MS
systems in VGS identification with a larger number of VGS
species and a wider sample type base, using a combination of
16S rRNA gene and gyrB sequencing as a gold standard. Overall,
the Vitek MS IVD system performed better than the Bruker
Biotyper, accurately identifying 98.9% of the 181 VGS isolates,
compared to 88.4% for Bruker Biotyper (P < 0.05). The lower
overall performance of the Bruker Biotyper MS was due to
misidentification of species within the mitis group, with 21 non-
pneumococcal isolates misidentified as S. pneumoniae, which is
in agreement with previous studies (Ikryannikova et al., 2011,
2013; Lopez Roa et al., 2013). Notably, we evaluated for the
first time, the performance of Vitek MS RUO system though
the results were not satisfying. However, this database covers
rare VGS species not included in the Vitek MS IVD system
(Karpanoja et al., 2014).
The superior performance of Vitek MS IVD in distinguishing
S. pneumoniae from other mitis group species may be due to
use of bin-weighting algorithms in species identification. The
system identifies significant peaks of sample isolates and divides
them into bins that are weighted according to frequency within
a given species. Then the sums of bin weights are calculated
using the advanced spectrum classifier algorithm to determine
the best match, which may enhance sensitivity (Rychert et al.,
2013). In contrast, Bruker Biotyper uses a single reference strain
to generate multiple spectra and chooses a consensus spectra
based on the reference spectra. After this, matching signals of the
sample spectra are compared to the reference spectra and a score
value is created (Welker, 2011).
Based on our findings, we designed an identification algorithm
for the best way to identify species within the VGS group
(Figure 2). Laboratories with either of the instruments could
refer to this algorithm easily. For Bruker Biotyper MS system,
strains with identification scores <1.7 must be re-tested since
VGS are very homologous species. Any identification of S.
pneumoniae even with a score of >2.0, should be discounted,
optochin test and gene-based analysis need to be performed for
confirmation. For Vitek MS, initial identification results with a
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FIGURE 2 | An identification testing algorithm for viridans group streptococci (VGS) based on the Bruker Biotyper MS system/Vitek MS system and
selective molecular identification (see Supplementary Tables S3 and S4).
aFor Bruker Biotyper MS system, strains with identification scores <1.7 must be re-tested.
bAny identification of S. pneumoniae even with a score of >2.0, should be preliminatory and then do further sequencing for the high incorrect identification rate.
Gene-based analysis confirmed that 85 out of the 106 isolates were S. pneumoniae while the rest are non-S. pneumoniae (Supplementary Table S3).
cFor Vitek MS, initial identification results with a confidence value <99.9% for a single isolate or with multiple/no identification results, must be repeated
(Supplementary Table S4).
confidence value <99.9% for a single result or with multiple/no
identification results, must be repeated. If the repeat analysis
fails to provide a high confidence value, these isolates should be
identified by molecular methods.
Study limitations include possible selection bias as isolates
were from a single center, imbalance in group/species
distribution of isolates, with some groups and species poorly
represented, e.g., the bovis and salivarius groups. And finally,
for uniformity, protein extraction step was not performed for all
assays.
SUMMARY
This study shows that both the Bruker Biotyper and the Vitek
MS IVD systems can provide a good alternative to phenotypic
methods for VGS identification. However, further improvements
in the data bases are needed to increase the identification
accuracy. In the mean-time, gene-based sequencing remains
the best way to correctly identify VGS species. The proposed
integrated algorithm is a practical approach in VGS identification
at this stage.
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